Martin NK - Search Results

1

Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia.

Hellard ME, Jenkinson R, Higgs P, Stoové MA, Sacks-Davis R, Gold J, Hickman M, Vickerman P, Martin NK. Hellard ME, et al. Among authors: martin nk. Med J Aust. 2012 Jun 4;196(10):638-41. doi: 10.5694/mja11.10981. Med J Aust. 2012. PMID: 22676879

2

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility.

Martin NK, Vickerman P, Foster GR, Hutchinson SJ, Goldberg DJ, Hickman M. Martin NK, et al. J Hepatol. 2011 Jun;54(6):1137-44. doi: 10.1016/j.jhep.2010.08.029. Epub 2011 Feb 12. J Hepatol. 2011. PMID: 21145810

3

Mathematical modelling of hepatitis C treatment for injecting drug users.

Martin NK, Vickerman P, Hickman M. Martin NK, et al. J Theor Biol. 2011 Apr 7;274(1):58-66. doi: 10.1016/j.jtbi.2010.12.041. Epub 2011 Jan 12. J Theor Biol. 2011. PMID: 21236265

4

Optimal control of hepatitis C antiviral treatment programme delivery for prevention amongst a population of injecting drug users.

Martin NK, Pitcher AB, Vickerman P, Vassall A, Hickman M. Martin NK, et al. PLoS One. 2011;6(8):e22309. doi: 10.1371/journal.pone.0022309. Epub 2011 Aug 11. PLoS One. 2011. PMID: 21853030 Free PMC article.

5

Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations.

Martin NK, Vickerman P, Miners A, Foster GR, Hutchinson SJ, Goldberg DJ, Hickman M. Martin NK, et al. Hepatology. 2012 Jan;55(1):49-57. doi: 10.1002/hep.24656. Epub 2011 Dec 6. Hepatology. 2012. PMID: 21898506

6

Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings--implications for intervention impact.

Vickerman P, Martin NK, Hickman M. Vickerman P, et al. Among authors: martin nk. Drug Alcohol Depend. 2012 Jun 1;123(1-3):122-31. doi: 10.1016/j.drugalcdep.2011.10.032. Epub 2011 Dec 3. Drug Alcohol Depend. 2012. PMID: 22138540

7

Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?

Vickerman P, Martin NK, Roy A, Beattie T, Jarlais DD, Strathdee S, Wiessing L, Hickman M; EMCDDA Collaborative Group. Vickerman P, et al. Among authors: martin nk. Drug Alcohol Depend. 2013 Sep 1;132(1-2):172-81. doi: 10.1016/j.drugalcdep.2013.01.020. Epub 2013 Feb 28. Drug Alcohol Depend. 2013. PMID: 23453261

8

How cost-effective is hepatitis C virus treatment for people who inject drugs?

Martin NK, Vickerman P, Miners A, Hickman M. Martin NK, et al. J Gastroenterol Hepatol. 2013 Apr;28(4):590-2. doi: 10.1111/jgh.12113. J Gastroenterol Hepatol. 2013. PMID: 23527756 No abstract available.

9

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals.

Martin NK, Vickerman P, Grebely J, Hellard M, Hutchinson SJ, Lima VD, Foster GR, Dillon JF, Goldberg DJ, Dore GJ, Hickman M. Martin NK, et al. Hepatology. 2013 Nov;58(5):1598-609. doi: 10.1002/hep.26431. Epub 2013 Aug 26. Hepatology. 2013. PMID: 23553643 Free PMC article.

10

Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM.

Martin TC, Martin NK, Hickman M, Vickerman P, Page EE, Everett R, Gazzard BG, Nelson M. Martin TC, et al. Among authors: martin nk. AIDS. 2013 Oct 23;27(16):2551-7. doi: 10.1097/QAD.0b013e32836381cc. AIDS. 2013. PMID: 23736152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters